Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Feb;413(1-2):189-98.
doi: 10.1007/s11010-015-2652-3. Epub 2016 Feb 2.

Caffeic acid phenethyl ester activates pro-apoptotic and epithelial-mesenchymal transition-related genes in ovarian cancer cells A2780 and A2780cis

Affiliations

Caffeic acid phenethyl ester activates pro-apoptotic and epithelial-mesenchymal transition-related genes in ovarian cancer cells A2780 and A2780cis

Claudia Gherman et al. Mol Cell Biochem. 2016 Feb.

Abstract

Ovarian cancer is a highly aggressive pathology, displaying a poor prognosis and chemoresistance to classical therapy. The present study was conducted to evaluate the effect of caffeic acid phenethyl ester (CAPE) on survival of ovarian cancer cell lines, A2780 (sensitive to cisplatin) and A2780cis (resistant to cisplatin). MTT assay was used to evaluate cell viability, while the apoptotic processes were examined by flow cytometry and qRT-PCR. A reduction of cell proliferation and activation of the apoptosis was observed in both cell lines. qRT-PCR evaluation demonstrated the activation of the pro-apoptotic genes (BAD, CASP8, FAS, FADD, p53) in both cell lines. The limited therapeutic effect in A2780 cells is explained by the activation of epithelial-mesenchymal transition-related genes (ZEB1, ZEB2, or TGFBB1) as displayed by Ingenuity Network analysis. Overall data suggest that CAPE can be used as an alternative in sensitizing cells to chemotherapy.

Keywords: Apoptosis; Caffeic acid phenethyl ester; Epithelial–mesenchymal transition; Ovarian cancer cells.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Cancer Treat Res. 1994;73:217-48 - PubMed
    1. Int Immunopharmacol. 2004 Mar;4(3):429-36 - PubMed
    1. PLoS One. 2014 Jan 22;9(1):e86987 - PubMed
    1. J Inorg Biochem. 2007 Oct;101(10):1354-61 - PubMed
    1. Int J Clin Exp Pathol. 2015 Mar 01;8(3):2710-8 - PubMed

Publication types

MeSH terms

LinkOut - more resources